SCHEMBL2544358

SCHEMBL2544358

COS(=O)(=O)OCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4649209-A METHYLENE CHLORIDE, SULFUR TRIOXIDE, SODIUM (BI)CARBONATE STABILIZER OCCIDENTAL CHEMICAL CORPORATION (US) 1987-03-10 US claimed
US-4459374-A ADDITION OF HYDROGEN CHLORIDE EMITTING SUBSTANCE TO CONTROL CURING SUMITOMO DUREZ COMPANY, LTD. (JP) 1984-07-10 US claimed
US-20240066133-A1 THERAPEUTIC AGENTS AND CONJUGATES THEREOF AJ SCIENCES (YIXING) CO., LTD (CN) 2024-02-29 US disclosed
EP-4114417-A2 THERAPEUTIC AGENTS AND CONJUGATES THEREOF Beijing Xuanyi Pharmasciences Co., Ltd. (CN) 2023-01-11 EP disclosed
WO-2021178818-A2 THERAPEUTIC AGENTS AND CONJUGATES THEREOF BEIJING XUANYI PHARMASCIENCES CO., LTD. (CN) 2021-09-10 WO disclosed
US-20210107942-A1 TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE ARAIM PHARMACEUTICALS INC (US) 2021-04-15 US disclosed
US-10864253-B2 Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage ARAIM PHARMACEUTICALS, INC. (US) 2020-12-15 US disclosed
US-20200360476-A1 TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE ARAIM PHARMACEUTICALS, INC. 2020-11-19 US disclosed
CN-111346213-A Tissue protective peptides and peptide analogs for the prevention and treatment of diseases and disorders associated with tissue damage 阿拉伊姆药品公司 2020-06-30 CN disclosed
EP-3541824-A1 LIVER PRODRUGS OF MITOCHONDRIAL PROTON IONOPHORES Neurovive Pharmaceutical AB (SE) 2019-09-25 EP disclosed
US-20190134156-A1 TISSUE PROTECTIVE PEPTIDES FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE ARAIM PHARMACEUTICALS, INC. 2019-05-09 US disclosed
US-5202203-A Improved shelf life THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 1993-04-13 US disclosed
US-4649209-A METHYLENE CHLORIDE, SULFUR TRIOXIDE, SODIUM (BI)CARBONATE STABILIZER OCCIDENTAL CHEMICAL CORPORATION (US) 1987-03-10 US disclosed
US-4649209-A METHYLENE CHLORIDE, SULFUR TRIOXIDE, SODIUM (BI)CARBONATE STABILIZER OCCIDENTAL CHEMICAL CORPORATION (US) 1987-03-10 US disclosed
US-4649209-A METHYLENE CHLORIDE, SULFUR TRIOXIDE, SODIUM (BI)CARBONATE STABILIZER OCCIDENTAL CHEMICAL CORPORATION (US) 1987-03-10 US disclosed
US-4594180-A Doping with a sulfonate compound SHOWA DENKO K.K. (JP) 1986-06-10 US disclosed
US-4487709-A (FUMING) NITRIC OR SULFURIC ACID, HALOALKYLSULFONATE, CHLORO- OR FLUOROSULFURIC ACID- SHOWA DENKO K.K. (JP) 1984-12-11 US disclosed
US-4459374-A ADDITION OF HYDROGEN CHLORIDE EMITTING SUBSTANCE TO CONTROL CURING SUMITOMO DUREZ COMPANY, LTD. (JP) 1984-07-10 US disclosed
US-4459374-A ADDITION OF HYDROGEN CHLORIDE EMITTING SUBSTANCE TO CONTROL CURING SUMITOMO DUREZ COMPANY, LTD. (JP) 1984-07-10 US disclosed
EP-0026234-A1 PROCESS FOR PREPARING HIGHLY CONDUCTIVE ACETYLENE HIGH POLYMER SHOWA DENKO KABUSHIKI KAISHA (JP) 1981-04-08 EP disclosed